CAMBRIDGE, Mass., Feb. 23, 2011 /PRNewswire/ -- Idenix
Pharmaceuticals, Inc. (Nasdaq: IDIX), announced today that Idenix
management will present a corporate overview at the Citi 2011
Global Healthcare Conference on March 2,
2011 at 3:30 p.m. ET at the
Hilton New York Hotel, New York
City.
The live and archived webcast of the company presentation can be
accessed under "Calendar of Events" in the Idenix Investor Center
at www.idenix.com. Please log in approximately 5-10 minutes before
each event to ensure a timely connection. The archived replay will
be available on the Idenix website for two weeks following the
conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical company engaged in the discovery and development
of drugs for the treatment of human viral diseases. Idenix's
current focus is on the treatment of patients with chronic
hepatitis C infection. For further information about Idenix, please
refer to http://www.idenix.com.
Idenix Pharmaceuticals
Contacts:
|
|
Kelly Barry (617) 995-9033
(media)
|
|
Eric Hoffman (617) 224-4485
(investors)
|
|
|
SOURCE Idenix Pharmaceuticals, Inc.